*11-Oxygenation index: results No. of cases 11-Oxygenation index Normals 48 0-32+0 19 (SD) Adrenal hyperplasia: 21-block 11 1-0-4-8 1 1-block 1 8-4 Adrenal tumour 1 0-5 1 l-deoxy 0 1 -Oxygenation index = 17-hydroxycorticosteroids 1 1-oxy crine disease were studied (Table 1 ). There was no variation with age or sex and normal index values were obtained in very sick infants and in postoperative cases. The mean value is 0-32 ±019 (SD). In 11 cases of classical adrenal hyperplasia the index ranged between 1 0 and 4-8 and the one hypertensive case gave an index value of 8 4. Apart from the value in the rapid diagnosis of adrenal hyperplasia, the index has helped in excluding the diagnosis in a virilized girl who was subsequently found to have an adrenal tumour. In one male infant of 2 weeks adrenal hyperplasia was suspected on clinical grounds, and the 17-oxosteroid excretion of 1-3 mg/24 h was difficult to interpret at this age. The 11oxygenation index was normal and treatment was withheld. A week later the 17-oxosteroid excretion was 0-15 mg/24 h.
Results in the immediate post-natal period must still be interpreted with caution because of the predominance of the 6p-hydroxylation metabolism over A-ring reduction. 63-hydroxy-11deoxy-cortisol appears in the 1 1-oxysteroid fraction after processing and thus may give a falsely low value of the index. Modified chromatographic systems are under investigation.
The steroid excretion of most of these cases has been intensively studied by systematic twodimensional chromatography (Edwards 1962). In two cases testosterone was tentatively identified.
Nature ofthe Virilizing Stimulus
The work of Jost (1953) has thrown light upon the factors governing the differentiation of the genital system. The gonads differentiate at the sixth week of intrauterine life. Gonadectomy at that time results in the development of a female internal genital system and the local presence of the testis during a short critical period is required for the development of a normal male internal genital system. Testosterone does not mimic this action, for it fails to suppress mullerian structures. In the case of the external genitalia, the basic pattern is again female and the masculine arrangement is only produced in the presence of a testicular secretion which can be exactly replaced by the exogenous testosterone.
The possibility that testosterone is the active androgenic agent in these cases is supported by the observation that it has been isolated from-the adrenal gland and that an adrenal homogenate can convert pregnenolone to testosterone. The finding of virilization and normal 17-oxosteroid excretion in some of the hypertensive cases is a point against a significant action by a weak androgen such as dehydroepiandrosterone.
The variety of adrenal hyperplasia described by Bongiovanni (1961) is of interest in this respect.
There appears to be a defect in 3fl-hydroxysteroid dehydrogenase activity. There is usually, but not always, severe salt loss. Females are mildly virilized, but males have hypospadias and may have cryptorchidism. It is possible that the block is present in the testis as well as the adrenal, and interferes with testosterone synthesis. In that case, testosterone would not be responsible for the mild virilization of the females.
Although the central biochemical problem of adrenal hyperplasia is now well understood, the secondary effects of the metabolic block demand further study, and the possibility that other undescribed blocks occur must be kept in mind. Virilization and the Human Ovary: Including Observations on the Stein-Leventhal Syndrome Hirsutism or virilism may be seen in patients with tumours of the ovary or the Stein-Leventhal syndrome in whom 17-oxosteroid (17-OS) excretion is normal, suggesting secretion of small amounts of a potent androgen. For example, a patientwith a large cystic granulosa cell tumour excreted only 9.9 mg 17-OS daily at a time when she had had moderate hirsuties and clitoral hypertrophy for one year. In this case the ratios of 17-deoxy-17-OS to 1 1-oxyetiocholanolones and to 1 1-hydroxyandrosterone excreted were apparently slightly elevated to 7 8 and 9 4 respectively (cf. normal 'Present address Addenbrooke's Hospital, Cambridge values 5 8 and 7 O respectively," seeP'runty -1964). The urinary excretion of cstrone, cestradiol and aestriol was normal (Dr R D Bulbrook). One year after removal of the tumour the 17-OS excretion was 6-2 mg daily, but it is doubtful if this is a significant fall. In vitro incubation of the tumour yielded testosterone from [4-14C]-progesterone in 0-6% yield (Mills et al. 1959) . The 17-OS excretory pattern was here consistent with a small increase of testosterone secretion. In a second patient who had shown virilism for five years the urinary excretion of 17-OS was only 12-5 mg daily. A typical small hilus cell tumour, containing numerous Reinke crystalloids, was removed and a small Brenner tumour from the contralateral ovary. Urinary 17-OS excretion remained at 11 -0 mg daily.
A much more common condition in which there is clinical evidence of excess ovarian androgen formation is the Stein-Leventhal syndrome. Our patients have been classified into those with mild to moderately severe virilization. In a total series of 42 cases important features have always included menstrual chaos and polycystic ovaries. When carefully examined the theca was usually very hyperplastic (Jones 1962) . The pre-operative diagnosis was normally confirmed by demonstration of at least minor ovarian enlargement by pneumoperitoneal radiography, although enlargement is not absolutely essential. In this group of patients 95 % were hirsute in some degree and only 57% obese. Ovulatory cycles occurred in over 80% after wedge resection, but no female babies born after operation showed virilism.
In these cases urinary 17-OS varied from low normal to slightly raised values (12/36 cases in the latter category). In 7 patients studied there was 60% depression of 17-OS after three days' administration of 6 mg dexamethasone, including one patient (SB 17) in whom no depression occurred. Responses to metyrapone in 3 patients studied were normal with respect to 17-OS excretion. It has been previously noted that there is a slight relatively increased response of 17-OS excretion to ACTH and that a small relative increase of 1 l-hydroxyandrosterone occurs, particularly after ACTH administration (Brooks & Prunty 1960) . The new finding that the level of testosterone in peripheral blood is depressed after dexamethasone administration (Casey & Kellie 1964) is compatible with the deduction from the above data that much of the 17-OS excreted is of adrenal origin in these cases. The possibility remains that there may be a small abnormal increase in these patients of adrenal secretion of Cl9 androgenic steroid. On the other hand there is much evidence that the normal ovarian conversion of androgen to cestrogen is disturbed in these patients. Short & London (1961) first demonstrated that the concentration of androstenedione was elevated and of cestrone and cestradiol-1 7 P reduced in the cyst fluid. This observation has been confirmed (Short 1962 , Baulieu et al. 1963 ) and extended to show that dehydroepiandrosterone (DHA) concentration may increase. However the presence of DHA-sulphate or testosterone has not been detected. In vitro biosynthesis of androstenedione, DHA and testosterone has been reported to be increased and of oestradiol-1 7 P to be decreased (Axelrod & Goldzieher 1962 , Lanthier & Sandor 1962 , Leon et al. 1962 ). The first two of these steroids have been found to be present in ovarian vein blood, but testosterone has not so far been detected ). These findings have suggested that the major steroid abnormality is impaired conversion of androstenedione to cestrogen. This at the moment is difficult to reconcile with the finding in our patients of normal, rather than low, cestrogen excretion, taking into account the stage of the menstrual cycle (Table 1) . Two of the patients studied were those also examined by Short & London (1961) . Normal oestrogen excretion has also been recorded by Brown & Mathew (1962) and Giorgi (1963) (see also Brown 1960) .
Studies have been made on the apparent pro- .cj.. precursors. Results are recorded in Table 2 . Those in patients with the Stein-Leventhal syndrome may be compared with those in the 6 patients in the upper part of Table 2. Patient MH was especially interesting in that she was unexpectedly one month pregnant at the time of observation as shown at laparotomy a month later. Patients SB 17 and SB 16 were girls with severe virilism with signs of baldness, clitoral hypertrophy and primary amenorrhcea. In the latter patient a small granulosa cell tumour was found embedded in one of the typical Stein-Leventhal ovaries. All the values for the apparent production of DHA fall within our normal range and that of Vande Wiele et al. (1963) . Those on suppression with 4 or 6 mg of dexamethasone daily are very much lower and there is no clear indication of a difference in the two groups. The observation quoted above of the absence of DHA-sulphate in ovarian tissue suggests at the moment that the apparent production rate of DHA during dexamethasone suppression may not be influenced by the presence of this compound.
5-
Testosterone production measures testosterone actually secreted, if any, and the net conversion of androstenedione to testosterone. This steroid i;s the most potent known androgen. Table 2 shows that values are lower on dexamethasone suppression. In 4 Stein-Leventhal patients the values appear to be raised and may be compared with 3
figures, reported in the literature, between 1V7 and 2-0 mg per day in unsuppressed normal women (Korenman et al. 1963 , Vande Wiele et al. 1963 . The reduction in apparent production of DHA and production of testosterone in 3 patients subjected to subtotal ovariectomy on account of severe virilism is specially notable. The suppressive effect of the ICI compound 33828 (la-allylthiocarbamoyl-2-methylthiocarbamoylhydrazine) (Bell, Brown, Fotherby & Loraine 1962 , Bell, Brown, Fotherby, Loraine & Robson 1962 ) on the ovaries of 2 patients (SB 17 and SB 16) has been investigated. In both it produced a significant fall in urinary total gonadotrophin excretion from 16 to 3 5 mg/day and from 10 to <2 mg/day respectively (Fig 1) , with a subsequent return to baseline. The initial levels were normal as in 12 other cases with this syndrome. The 17-OS excretion was suppressed (Fig 2) in both cases, especially the first. DHA apparent production and testosterone production also showed a marked fall. In the first patient the production of testosterone on dexamethasone was 9 0 mg daily and even fell to 5 mg daily on the ICI compound alone. In the second patient dexamethasone was given both for the control observation and during administration of the ICI compound, the values being 2 5 and 1-0 mg daily.
These observations indicate a fall in androgen production in these patients as a result of administ,ration of ICI 33828, probably as a result of reduced gonadotrophin secretion by the pituitary.
The results presented in this paper suggest that abnormal ovaries can secrete abnormal amounts of potent androgen in vivo, which may be insufficient to cause abnormally high urinary 17-OS excretion, and that subtotal ovariectomy largely abolishes this condition. The compound ICI 33828 can reduce a normal gonadotrophin excretion to low levels a process accompanied by reduction of androgen production. More needs to be learnt about the action of this compound. 
